Crucial Role of Jak2V617f-positive Myeloproliferative Neoplasm in the Development of Aortic Aneurysm

被引：0
|
作者：
Yokokawa, Tetsuro
Misaka, Tomofumi
Kimishima, Yusuke
Wada, Kento
Minakawa, Keiji
Sugimoto, Koichi
Ishida, Takafumi
Ikeda, Kazuhiko
Takeishi, Yasuchika
机构：
来源：
CIRCULATION | 2020年 / 142卷
关键词：
D O I：
10.1161/circ.142.suppl_3.12726
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A12726
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera
    Cherry, Mohamad
    Khawandanah, Mohamad
    Zhao, Zhizhuang Joe
    Srour, Samer
    Ozer, Howard
    Selby, George
    Ghabache, Bassam
    Al-Kali, Aref
    ANNALS OF HEMATOLOGY, 2015, 94 (04) : 717 - 719
  • [32] Gain of function in Jak2V617F-positive T-cells
    G Nishanth
    D Wolleschak
    C Fahldieck
    T Fischer
    A Mullally
    F Perner
    T M Schnöder
    S Just
    F H Heidel
    D Schlüter
    Leukemia, 2017, 31 : 1000 - 1003
  • [33] Molecular Analysis of JAK2V617F-Positive Myeloproliferative Neoplasms Reveals Wnt/ß-Catenin As a Potential Target for Therapy
    Gu Wenjing
    Tong, Jingyuan
    Fu, Rongfeng
    Shi, Lihong
    Zhang, Lei
    BLOOD, 2022, 140 : 9577 - 9579
  • [34] IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms
    Campos, Paula de Melo
    Machado-Neto, Joao A.
    Eide, Christopher A.
    Savage, Samantha L.
    Scopim-Ribeiro, Renata
    Souza Duarte, Adriana da Silva
    Favaro, Patricia
    Lorand-Metze, Irene
    Costa, Fernando F.
    Tognon, Cristina E.
    Druker, Brian J.
    Olalla Saad, Sara T.
    Traina, Fabiola
    ONCOTARGET, 2016, 7 (06) : 6948 - 6959
  • [35] The thrombopoietin receptor, MPL, is critical for development of a JAK2V617F-induced myeloproliferative neoplasm
    Sangkhae, Veena
    Etheridge, S. Leah
    Kaushansky, Kenneth
    Hitchcock, Ian S.
    BLOOD, 2014, 124 (26) : 3956 - 3963
  • [36] JAK2V617F-Positive Latent Essential Thrombocythemia and Splanchnic Vein Thrombosis: The Role of Bone Marrow Biopsy for the Diagnosis of Myeloproliferative Disease
    Allegra, Alessandro
    Alonci, Andrea
    Penna, Giuseppa
    D'Angelo, Arianna
    Rizzotti, Patricia
    Granata, Angela
    Musolino, Caterina
    ACTA HAEMATOLOGICA, 2009, 121 (04) : 218 - 220
  • [37] Transient ischemic attacks as the first presentation of JAK2-V617F positive chronic myeloproliferative neoplasm
    Kalala, Fani
    Mamara, Antigoni
    Ioannou, Maria
    Speletas, Matthaios
    HEMATOLOGY REPORTS, 2012, 4 (02) : 34 - 36
  • [38] JAK2 (V617F) Positive Latent Myeloproliferative Neoplasm Presenting with Splanchnic Vein Thrombosis
    Salhotra, Amandeep
    Oo, Thein H.
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2014, 30 : S4 - S8
  • [39] JAK2 (V617F) Positive Latent Myeloproliferative Neoplasm Presenting with Splanchnic Vein Thrombosis
    Amandeep Salhotra
    Thein H. Oo
    Indian Journal of Hematology and Blood Transfusion, 2014, 30 : 4 - 8
  • [40] Gene expression profiling distinguishes JAK2V617F-negative from JAK2V617F-positive patients in essential thrombocythemia
    Puigdecanet, E.
    Espinet, B.
    Lozano, J. J.
    Sumoy, L.
    Bellosillo, B.
    Arenillas, L.
    Alvarez-Larran, A.
    Sole, F.
    Serrano, S.
    Besses, C.
    Florensa, L.
    LEUKEMIA, 2008, 22 (07) : 1368 - 1376
12345